Immunome, Inc. ( IMNM) - Key Metrics
IMNM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.05 | -$0.50 | -$0.57 | -$0.58 |
| 2025Q1 | $0.04 | -$0.52 | -$0.67 | -$0.71 |
IMNM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -4.66 |
| 2025Q1 | ? | -3.21 |
IMNM
Price: $18.07
52 week price:
Earnings Per Share: -2.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8759
Market Capitalization: 1.9 billion